Primex Nears Market With Oral Pediatric Sedation Solution

Switzerland’s fast-growing critical-care company Primex has submitted for approval what it believes is the first oral solution for the mild to moderate sedation of anxious children undergoing surgical and diagnostic procedures, with a launch in Europe penciled in for a year’s time.

Kari Sarvanto
Primex's Kari Sarvanto • Source: Primex

Anesthesiology is often overlooked by pharma, and many believe there has been little innovation in the area since propofol was developed 30 years ago, but the fast-growing Swiss company Primex Pharmaceuticals AG wants to change that perception.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from R&D

More from Scrip